Nearly three years ago, Konica Minolta acquired two U.S.-based medical companies, genetics testing company Ambry Genetics Corporation (see “Konica Minolta to Buy U.S.-Based Ambry Genetics for $1 Billion”) and Invicro LLC, a contract research organization (CRO) that uses imaging technology and data analytics for drug development (see “Konica Minolta Strengthens Healthcare Position with Invicro Acquisition”).
